Physiology and pharmacology of myocardial preconditioning and postconditioning

Semin Cardiothorac Vasc Anesth. 2009 Mar;13(1):5-18. doi: 10.1177/1089253208330709. Epub 2009 Mar 26.

Abstract

Perioperative myocardial ischemia and infarction are not only major sources of morbidity and mortality in patients undergoing surgery but also important causes of prolonged hospital stay and resource utilization. Ischemic and pharmacological preconditioning and postconditioning have been known for more than 2 decades to provide protection against myocardial ischemia and reperfusion and limit myocardial infarct size in many experimental animal models, as well as in clinical studies. This article reviews the physiology and pharmacology of ischemic and drug-induced preconditioning and postconditioning of the myocardium with special emphasis on the mechanisms by which volatile anesthetics provide myocardial protection. Insights gained from animal and clinical studies are reviewed and recommendations given for the use of perioperative anesthetics and medications.

Publication types

  • Review

MeSH terms

  • Aged
  • Aging / physiology
  • Cardiotonic Agents / therapeutic use
  • Diabetes Complications / therapy
  • Heart / drug effects
  • Heart Diseases / physiopathology
  • Humans
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / therapy
  • Ischemic Preconditioning, Myocardial / methods*
  • Myocardial Infarction / prevention & control
  • Myocardial Ischemia / therapy
  • Reperfusion Injury / prevention & control

Substances

  • Cardiotonic Agents